Biochemical and Biophysical Research Communications 2014-07-04

Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.

Gyrid Nygaard, Lars Herfindal, Reidun Kopperud, Anna M Aragay, Holm Holmsen, Stein Ove Døskeland, Rune Kleppe, Frode Selheim

Index: Biochem. Biophys. Res. Commun. 449(3) , 357-63, (2014)

Full Text: HTML

Abstract

In platelets, nitric oxide (NO) activates cGMP/PKG signalling, whereas prostaglandins and adenosine signal through cAMP/PKA. Cyclic nucleotide signalling has been considered to play an inhibitory role in platelets. However, an early stimulatory effect of NO and cGMP-PKG signalling in low dose agonist-induced platelet activation have recently been suggested. Here, we investigated whether different experimental conditions could explain some of the discrepancy reported for platelet cGMP-PKG-signalling. We treated gel-filtered human platelets with cGMP and cAMP analogues, and used flow cytometric assays to detect low dose thrombin-induced formation of small platelet aggregates, single platelet disappearance (SPD), platelet-derived microparticles (PMP) and thrombin receptor agonist peptide (TRAP)-induced P-selectin expression. All four agonist-induced platelet activation phases were blocked when platelets were costimulated with the PKG activators 8-Br-PET-cGMP or 8-pCPT-cGMP and low-doses of thrombin or TRAP. However, extended incubation with 8-Br-PET-cGMP decreased its inhibition of TRAP-induced P-selectin expression in a time-dependent manner. This effect did not involve desensitisation of PKG or PKA activity, measured as site-specific VASP phosphorylation. Moreover, PKG activators in combination with the PKA activator Sp-5,6-DCL-cBIMPS revealed additive inhibitory effect on TRAP-induced P-selectin expression. Taken together, we found no evidence for a stimulatory role of cGMP/PKG in platelets activation and conclude rather that cGMP/PKG signalling has an important inhibitory function in human platelet activation. Copyright © 2014 Elsevier Inc. All rights reserved.

Related Compounds

Structure Name/CAS No. Articles
Guanosine 3',5'-cyclic monophosphate Structure Guanosine 3',5'-cyclic monophosphate
CAS:7665-99-8
8-(4-CHLOROPHENYLTHIO)GUANOSINE 3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT Structure 8-(4-CHLOROPHENYLTHIO)GUANOSINE 3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT
CAS:51239-26-0
Adenosine cyclophosphate Structure Adenosine cyclophosphate
CAS:60-92-4
5,6-Dichlorobenzimidazole riboside Structure 5,6-Dichlorobenzimidazole riboside
CAS:53-85-0
camp sodium salt Structure camp sodium salt
CAS:37839-81-9